Foghorn Therapeutics Stock Forecast

Buy or Hold candidate since Jun 26, 2026 Gain 28.91%

The Foghorn Therapeutics Inc. stock price fell by -8.57% on the last day (Monday, 13th Jul 2026) from $5.95 to $5.44. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 10.61% from a day low at $5.37 to a day high of $5.94. The price has risen in 6 of the last 10 days and is up by 28.91% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -8 thousand shares and in total, 286 thousand shares were bought and sold for approximately $1.55 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Foghorn Therapeutics Inc. stock with a 90% probability to be traded between $3.56 and $6.14 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

FHTX Signals & Forecast

The Foghorn Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $5.70. On a fall, the stock will find some support from the long-term average at approximately $4.45. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -11.83%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Foghorn Therapeutics Inc. stock

Foghorn Therapeutics Inc. finds support from accumulated volume at $5.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.570 between high and low, or 10.61%. For the last week, the stock has had daily average volatility of 12.16%.

Our recommended stop-loss: $5.13 (-5.64%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (FHTX) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Foghorn Therapeutics Inc. to open at $5.58, and during the day (based on 14 day Average True Range), to move between $5.24 and $5.64, which gives a possible trading interval of +/-$0.396 (+/-7.56%) up or down from last closing price. If Foghorn Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.56% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.30 (2.57%) than the resistance at $6.00 (10.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Foghorn Therapeutics Inc. stock A Buy?

Foghorn Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.477 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $5.58 ( 2.63%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk